Press coverage about Cogentix Medical (NASDAQ:CGNT) has trended positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cogentix Medical earned a media sentiment score of 0.28 on Accern’s scale. Accern also gave media stories about the medical device company an impact score of 44.7057331506653 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:
- Accelmed fund makes 250% on Cogentix exit (globes.co.il)
- Cogentix Medical (CGNT) Downgraded by Aegis to Hold (americanbankingnews.com)
- Accelmed fund makes 220% on Cogentix exit (globes.co.il)
- Laborie Medical to pay $214m for Cogentix (massdevice.com)
- Cogentix Medical (CGNT) to be Acquired by Laborie Medical Technologies for $3.85 Per Share in Cash (streetinsider.com)
Cogentix Medical (CGNT) remained flat at $$3.84 during trading on Wednesday. 211,523 shares of the company’s stock were exchanged, compared to its average volume of 160,234. The firm has a market cap of $232.66, a P/E ratio of -9.34 and a beta of 0.75. Cogentix Medical has a twelve month low of $1.55 and a twelve month high of $3.89.
About Cogentix Medical
Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).
Receive News & Ratings for Cogentix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical and related companies with MarketBeat.com's FREE daily email newsletter.